Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giampietro Pellizzer is active.

Publication


Featured researches published by Giampietro Pellizzer.


Diabetic Medicine | 2001

Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb‐threatening diabetic foot infection

Giampietro Pellizzer; M. Strazzabosco; S. Presi; F. Furlan; L. Lora; Paolo Benedetti; M. Bonato; G. Erle; F. De Lalla

Aims  The results of ulcer swabbing vs. deep tissue biopsy have been compared prospectively in 29 diabetic patients with limb‐threatening foot infection, to investigate the effectiveness and reliability of each method, and to evaluate whether any of the two could be more suitable for the microbiological follow‐up of severe lesions.


BMC Infectious Diseases | 2011

Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system

Ugo Fedeli; Elena Schievano; Dora Buonfrate; Giampietro Pellizzer; Paolo Spolaore

BackgroundFew population-based studies provide epidemiological data on infective endocarditis (IE). Aim of the study is to analyze incidence and outcomes of IE in the Veneto Region (North-Eastern Italy).MethodsResidents with a first hospitalization for IE in 2000-2008 were extracted from discharge data and linked to mortality records to estimate 365-days survival. Etiology was retrieved in subsets of this cohort by discharge codes and by linkage to a microbiological database. Risk factors for mortality were assessed through logistic regression.Results1,863 subjects were hospitalized for IE, with a corresponding crude rate of 4.4 per 100,000 person-years, increasing from 4.1 in 2000-2002 to 4.9 in 2006-2008 (p = 0.003). Median age was 68 years; 39% of subjects were hospitalized in the three preceding months. 23% of patients underwent a cardiac valve procedure in the index admission or in the following year. Inhospital mortality was 14% (19% including hospital transfers); 90-days and 365-days mortality rose through the study years. Mortality increased with age and the Charlson comorbidity index, in subjects with previous hospitalizations for heart failure, and (in the subcohort with microbiological data) in IE due to Staphylococci (40% of IE).ConclusionsThe study demonstrates an increasing incidence and mortality for IE over the last decade. Analyses of electronic archives provide a region-wide picture of IE, overcoming referral biases affecting single clinic or multicentric studies, and therefore represent a first fundamental step to detect critical issues related to IE.


European Journal of Epidemiology | 1996

Investigation of a Q-fever outbreak in Northern Italy

T. Manfredi Selvaggi; Giovanni Rezza; Mariuccia Scagnelli; R. Rigoli; Mario Rassu; F. de Lalla; Giampietro Pellizzer; A. Tramarin; C. Bettini; L. Zampieri; M. Belloni; E. Dalla Pozza; S. Marangon; N. Marchiorettos; G. Togni; M. Giacobbo; A. Todescato; Nancy J. Binkin

AbstractObjectives: A study was conducted to evaluate the extent of a Q-fever epidemic through active case finding in the area of Vicenza (northeastern Italy), and to identify risk factors for Q-fever in this outbreak. Methods: 1) Descriptive epidemiology; 2) Seroepidemiological survey; 3) Case-control study. 1) Epidemic curve and maps with the location of cases. Identification of the road followed by the flocks of sheep. 2) Cross-sectional study on humans and flocks of sheep tested for anti-Coxiella burnetii antibodies. 3) Cases were defined by the presence of fever > 38 °C plus serological confirmation. Controls were 94 apparently healthy individuals attending outpatient facilities for control visits or certification, group-matched by geographical area, age and gender. A standardized questionnaire was administered by trained interviewers. Odds ratio and 95% confidence intervals (CI) were used to evaluate risk factors for Q-fever. Results: A total of 58 cases were identified in a 5-month period. Male to female ratio was 2.8:1; mean age was 42 years (range: 20–65 years). Twenty-eight patients (48%) were hospitalized. Fever was accompanied by asthenia (81%), headache (76%), chills (72%), and myalgia and arthralgia (53%); cough was present in 47% of patients. Rx abnormalities were found in 81 % of the patients undergoing chest X-ray. Among 111 apparently healthy family members who underwent serological testing, four (3.6%) had antibodies to Coxiella burnetii. Three flocks which passed through the outbreak area between late May and early June were shown to be infected, with prevalence of antibodies ranging between 45 and 53%. The case-control study showed a significant association with exposure to flocks of sheep (Odds ratio = 6.1; 95% CI 2.5, 16.3). Other potential risk factors were not more commonly reported by cases with respect to controls. Conclusions: Indirect exposure to flocks of sheep was a determinant of this outbreak of Q-fever. This finding suggests that transmission occurred through inhalation of contaminated airborne particles. The importance of control measures should be stressed in areas traversed by flocks of sheep.


Infection | 2011

Septic shock, pneumonia, and soft tissue infection due to Myroides odoratimimus : report of a case and review of Myroides infections

Paolo Benedetti; Mario Rassu; G. Pavan; Armine Sefton; Giampietro Pellizzer

The genus Myroides comprises aerobic, yellow-pigmented, non-motile, non-fermenting gram-negative rods formerly classified as Flavobacterium odoratum. Members of the genus are widely distributed in the environment, especially in water, and usually behave as low-grade opportunistic pathogens, having been found to cause urinary tract infection, endocarditis, ventriculitis, and cutaneous infections in severely immunocompromised patients. We report a case of soft tissue infection, septic shock, and pneumonia due to M. odoratimimus in an immunocompetent male. To our knowledge, this is the first description of life-threatening infection caused by this organism in an immunocompetent host. We have also reviewed the medical literature on the genus Myroides.


Antimicrobial Agents and Chemotherapy | 1993

Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration.

F de Lalla; Andrea Novelli; Giampietro Pellizzer; F Milocchi; Renato Viola; A. Rigon; Clara Stecca; V Dal Pizzol; Stefania Fallani; P. Periti

Twenty-four patients undergoing monolateral or bilateral total knee replacement (TKR) procedures were randomized to receive teicoplanin (T) either systemically or regionally. Subjects scheduled for systemic prophylaxis and undergoing monolateral (six patients) or bilateral (five patients) TKR received a single 800-mg dose of T in 100 ml of saline as a 5-min infusion into a forearm vein 2.5 h before surgery. For regional prophylaxis, patients undergoing monolateral surgery (eight subjects) received 400 mg of T in 100 ml of saline as a 5-min infusion into a foot vein of the leg to be operated on immediately after the tourniquet was inflated. For the five patients scheduled for bilateral operation and regional prophylaxis, the administration of T was also repeated for the second knee operation. The tourniquet, as the standard TKR surgical technique, was inflated to 400 mm Hg (c. 50 kPa) in all 24 patients immediately before the beginning of surgery and kept in place for the duration of the operation. Samples of serum, bone, skin, synovia, and subcutaneous tissue were collected at timed intervals during surgery. They were microbiologically assayed for T by using Bacillus subtilis as the test organism. Overall, the mean T concentrations obtained with regional route prophylaxis were found to be 2 to 10 times higher than those achieved following systemic prophylaxis. Moreover, peak levels in different tissues after regional prophylaxis were significantly higher (P < 0.05). None of the patients experienced adverse effects due to regional or systemic T administration; no prosthetic or wound infections were observed in the follow-up period (from 12 to 26 months).


Antimicrobial Agents and Chemotherapy | 2000

Regional Prophylaxis with Teicoplanin in Monolateral or Bilateral Total Knee Replacement: an Open Study

Fausto de Lalla; Renato Viola; Giampietro Pellizzer; Luca Lazzarini; A. Tramarin; Paolo Fabris

ABSTRACT From January 1991 to June 1997, patients undergoing primary elective monolateral or bilateral total knee replacement (TKR) were consecutively enrolled in a prospective, open clinical study on the efficacy and safety of regional prophylaxis with teicoplanin (TEC). Those scheduled for monolateral TKR (115 patients) received 400 mg of TEC in 100 ml of saline as a 5-min infusion into a foot vein of the leg to be operated on immediately after the tourniquet was inflated to 400 mm Hg (ca. 50 kPa). For patients undergoing bilateral surgery (45 patients), regional administration of TEC was also repeated for the second knee operation. Follow-up ranged from a minimum of 2 years to 8 years. None of the patients experienced local or systemic adverse effects following regional administration of TEC. In the immediate postoperative and 2-year follow-up periods, only one superficial infection of the primary site attributable to intraoperative contamination (prophylaxis failure) out of the 205 prostheses implanted was observed. Deep infections involving the prosthesis did not occur. Infectious complications at distant sites were observed in nine cases (urinary tract infection due to Escherichia coli in eight cases, and Salmonella enteritidis gastroenteritis in one case) in the immediate postoperative period; they all were rapidly cured after antibiotic treatment. A delayed prosthetic infection, related to hematogenous spread of the etiological agent and therefore not considered a prophylactic failure, was observed in a patient who had undergone TKR 5 years before. Regional administration of TEC in monolateral and bilateral TKR appears to be a safe and valuable prophylactic technique.


Infection | 1992

HCV infection after accidental needlestick injury in health-care workers

F. Marranconi; V. Mecenero; Giampietro Pellizzer; M. C. Bettini; M.U. Conforto; Alberto Vaglia; Clara Stecca; E. Cardone; F. de Lalla

HBV (1) and HIV (2) infections can be transmitted to healthcare workers after accidental exposure to infected blood. According to recent reports [3,4], in a hospital setting, HCV infection can also occur following the same modalities of transmission. However, the extent of this is still poorly documented. We report the results of an observational study of accidental exposure to infected blood among the health-care personnel in our hospital. From the 1st of October 1989 to the 30th of September 1990, immediate notification was received of 225 risk exposures to infection in 206 subjects among the 2,347 health-care workers (108 needlestick injuries and 117 extensive cutaneous and/or mucous contacts with blood). On notification, all the injured health-care workers were tested for HBV markers (ELISA, Organon Teknika, Belgium) and anti-HIV-1 (ELISA, Organon Teknika, Belgium); 129 out of 225 (57.33%) were also tested for anti-HCV (Ortho HCV ELISA Test System, N. J., USA) and RIBA (Chiron RIBA HCV Test System, CA, USA) confirmed. Two out of 206 (0.97%) and one out of 129 (0.77%) health-care workers were found to be positive for HBsAg or anti-HCV, respectively, according to blood samples drawn at the time of notification (i.e. within a few hours of injury). None of them was found to be positive for HIV-1 or Delta antibodies. The presumed sources of infection were also examined on notification in 166 out of 225 cases. Of these, 19 of 166 (11.44%) were i.v. drug abusers. The pattern of serological markers in the presumed sources of infection is shown in Table 1. Up to March 1991, 117 out of the 206 (56.80%) health-care workers accidentally exposed were followed up for at least six months. Three cases of HCV seroconversion and none of either HBV or HIV-1 have been observed so far. The first seroconversion occurred in an orthopedic surgeon (


Public Health | 1994

Serological survey of hepatitis B infection in Tanzania

Giampietro Pellizzer; C. Blé; N. Zarnperetti; T. Stroffolini; G. Upunda; M. Rapicetta; P. Chionne; U. Villano; Paolo Fabris; F. de Lalla

1) who suffered a needlestick injury from a needle used in an anti-HCV-positive posttransfusional CAH. Five weeks later S1 developed acute hepatitis and 14 weeks later he seroconverted to anti-HCV. The second case occurred in a surgeon (


Journal of Chemotherapy | 2001

Postoperative Infections Following Total Knee Replacement: An Epidemiological Study

Luca Lazzarini; Giampietro Pellizzer; Clara Stecca; Renato Viola; F. De Lalla

2) who was injured with a needle used in an anti-HIV-1and anti-HBs-positive i.v. drug abuser [4]. At the time of the accident, the HCV serology status Table 1 : Pattern of serological markers in presumed sources of infections (PSIs) and i.v. drug abusers PSIs (IVDAs-PSIs).


Case Reports in Medicine | 2011

Fatal Myocarditis in Course of Plasmodium falciparum Infection: Case Report and Review of Cardiac Complications in Malaria

Paola Costenaro; Paolo Benedetti; Chiara Facchin; Carlo Mengoli; Giampietro Pellizzer

In 1992, the prevalence of hepatitis B virus (HBV) markers was evaluated in 1004 subjects aged one to 76 years living in urban and rural areas in Tanzania. The overall prevalence rates of hepatitis B surface antigen (HBsAg) and of any HBV marker were 4.4% and 37.0%, respectively. No statistically significant difference by sex was found. The HBsAg prevalence among pregnant women was 4.3% (20/463). The proportion of HBeAg positive among HBsAg positive pregnant women was 10% (2/20). The HBsAg age-specific prevalence was 2.1% in the 1-5 year age-group; peak prevalence (12.1%) occurred in the 6-15 year age-group. Markers of HBV infection were 4.1% by age five years; they increased with advancing age (P < 0.01). Subjects residing in urban areas had statistically significant higher HBV exposure than those residing in rural areas (43.9% vs 27.4%, P < 0.01). Subjects belonging to the largest family size (seven or more members) showed increasing risk (OR 2.9; 95% CI = 1.96-4.28) of HBV exposure. Because maternal HBV transmission early in life appears to be of minor impact and children are mostly infected later in infancy, HBV vaccination at birth is not indicated, while vaccination of all infants at 2-3 months of age with other paediatric vaccinations is the first priority.

Collaboration


Dive into the Giampietro Pellizzer's collaboration.

Top Co-Authors

Avatar

Clara Stecca

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marzia Franzetti

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Paolo Fabris

International School for Advanced Studies

View shared research outputs
Top Co-Authors

Avatar

Armine Sefton

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

F. De Lalla

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Mariuccia Scagnelli

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Domenico Infantolino

Laboratory of Molecular Biology

View shared research outputs
Researchain Logo
Decentralizing Knowledge